From cancer studies to neurodevelopment, from infectious disease models to regenerative medicine, organoids are emerging as a vital bridge between fundamental research and clinical applications.

A scientific perspective vividly describes proteins as locks and small-molecule activators or inhibitors as perfectly matched keys— they insert, turn, or jam the lock, thereby controlling the entire machinery of life. This metaphor, rooted in the classic "lock-and-key model" proposed by Emil Fischer in 1894, continues to gain new vitality in modern drug discovery and biology.

Research into NiV and Hendra virus is crucial for decoding infection mechanisms, improving diagnostics, and accelerating vaccine progress. To support these efforts, Bioss has launched a new series of high-quality recombinant protein products tailored to Nipah and Hendra viruses.

In life science research, antibodies are among the most fundamental experimental tools. However, unlike highly standardized laboratory consumables such as pipettes or culture media, antibodies are not products that “just work” by default. This is precisely why, when selecting antibodies, researchers almost invariably examine one key metric: citation count.

This article examines how IHC-based approaches are not only pivotal for neurodegenerative disorders but are also transformative across a spectrum of human diseases, including cancer and infectious diseases.

What elevates immunohistochemistry (IHC) to extraordinary precision? The answer is HRP polymer detection—a highly sensitive, streamlined method revolutionizing signal detection in IHC. In this article, we’ll dive into how it works, how it stacks up against traditional methods, and why it might be the right choice for your lab.